Financhill
Sell
46

LRMR Quote, Financials, Valuation and Earnings

Last price:
$3.81
Seasonality move :
40.5%
Day range:
$3.66 - $3.80
52-week range:
$1.61 - $6.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.28x
Volume:
623.7K
Avg. volume:
1.6M
1-year change:
-38.54%
Market cap:
$316.7M
Revenue:
--
EPS (TTM):
-$1.93

Earnings Data

Next earnings date for LRMR
Mar 30
2026
Most recent earnings per share
-$0.61
Missed by $0.19
(Nov 5/2025)
Consensus Estimate
-$0.42
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LRMR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/30/2026 Q4 -- -- -- -$0.55 --
11/05/2025 Q3 -- -- -$0.61 -$0.42 -$0.19
08/14/2025 Q2 -- -- -$0.41 -$0.49 $0.08
05/08/2025 Q1 -- -- -$0.46 -$0.41 -$0.05
03/24/2025 Q4 -- -- -$0.45 -$0.32 -$0.13
10/30/2024 Q3 -- -- -$0.24 -$0.37 $0.13
08/08/2024 Q2 -- -- -$0.34 -$0.32 -$0.02
05/09/2024 Q1 -- -- -$0.27 -$0.24 -$0.03
03/14/2024 Q4 -- -- -$0.29 -$0.25 -$0.04
11/14/2023 Q3 -- -- -$0.21 -$0.23 $0.02
08/10/2023 Q2 -- -- -$0.19 -$0.21 $0.02
05/15/2023 Q1 -- -- -$0.15 -$0.25 $0.10
03/14/2023 Q4 -- -- -$0.21 -$0.37 $0.16
11/10/2022 Q3 -- -- -$0.37 -$0.42 $0.05
08/11/2022 Q2 -- -- -$0.47 -$0.57 $0.10
05/12/2022 Q1 -- -- -$0.49 -$0.51 $0.02
03/25/2022 Q4 -- -- -$0.50 -$0.72 $0.22
11/12/2021 Q3 -- -- -$0.92 -$0.67 -$0.26
08/12/2021 Q2 -- -- -$0.79 -$0.75 -$0.04
05/10/2021 Q1 -- -- -$0.76 -$0.87 $0.11
03/04/2021 Q4 -- -- -$0.89 -$0.72 -$0.17
11/10/2020 Q3 -- -- -$0.64 -- --
08/11/2020 Q2 -- -- -$1.21 -- --

Larimar Therapeutics, Inc. Earnings Questions

  • How Much did Larimar Therapeutics, Inc. Generate in Revenue Last Quarter?

    Larimar Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Larimar Therapeutics, Inc. Beat Earnings Last Quarter?

    Larimar Therapeutics, Inc. announced earnings per share of -$0.61 which represents a miss of analyst forecast a -$0.42 per share.

  • Is Larimar Therapeutics, Inc. Profitable?

    Larimar Therapeutics, Inc. reported -$88K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Larimar Therapeutics, Inc. EPS Next Year?

    Larimar Therapeutics, Inc.'s earnings are forecast to decrease from -$1.32 per share to -$1.22 per share next year representing a decrease of -51.47%.

  • When is Larimar Therapeutics, Inc.'s Earnings Date?

    Larimar Therapeutics, Inc.'s next earnings date is March 30, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 65.66% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.34% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 4.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock